| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 03/11/2004 | US20040047918 Napthalamide compositions and uses thereof |
| 03/11/2004 | US20040047917 Drug delivery and targeting with vitamin B12 conjugates |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/11/2004 | US20040047856 Colorstrum-based composition |
| 03/11/2004 | US20040047839 Method of treating human immunodeficiency diseases with electroactivated aqueous salt solutions followed by reconstitution of a healthy microflora. |
| 03/11/2004 | US20040047835 Combinations of drug conjugates with other therapeutic agents, including chemotherapy drugs. The invention also provides methods of using the combinations for the treatment of diseases associated with cell proliferation such as tumors |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
| 03/11/2004 | DE10239161A1 Stimulating gastric function without causing undesirable side-effects, using nutritional supplement containing vitamin C and magnesium |
| 03/11/2004 | DE10219784A1 Orally administered solution used for rehydration, especially in diarrhea patients, is enclosed in taste masking carrier of absorbable polymer, specifically in form of microcapsules |
| 03/10/2004 | EP1396494A1 Magnesium (-)hydroxycitrate and its applications |
| 03/10/2004 | EP1396267A2 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 03/10/2004 | EP1395268A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 03/10/2004 | EP1395244A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/10/2004 | EP1395241A1 Implantable medical device with controllable gaseous agent release system |
| 03/10/2004 | EP1395133A2 Polymer controlled induced viscosity fiber system and uses thereof |
| 03/10/2004 | EP1395132A1 Dual viscosity fibre system and uses thereof |
| 03/10/2004 | EP1395128A2 Acid controlled viscosity fibre system and uses thereof |
| 03/10/2004 | CN1481256A Inhalation of nitric oxide |
| 03/10/2004 | CN1481249A 治疗hiv的方法 Hiv treatment methods |
| 03/10/2004 | CN1480203A Preparation of Chinese herbal medicine to be taken after being mixed with boiling water for removal of urinary calculus |
| 03/10/2004 | CN1480201A Formula of medication for treating bone fracture and contuse |
| 03/10/2004 | CN1480175A Pills for promoting reunion of bone, muscle and ligament |
| 03/10/2004 | CN1480153A Tinea cruris ointment |
| 03/10/2004 | CN1141132C Externally applied ointment for treating burns, wound and frost bite and its prepn method |
| 03/10/2004 | CN1141122C Chinese-herbal regulator for improving domestic animal |
| 03/10/2004 | CN1141116C Powdered medicine for treating pulmonary tuberculosis |
| 03/10/2004 | CN1141112C Chinese-medicinal ointment for treating burn and scald |
| 03/10/2004 | CN1141111C Far infrared gukangtie plaster and its prepn technique |
| 03/10/2004 | CN1141110C Capsule for treating cancer and its prepn method |
| 03/10/2004 | CN1141105C Cancer curing medicinal liquid |
| 03/09/2004 | US6703382 Promoting apoptosis by administering compounds such as 2,9-dimethoxy-11,12-dihydrodibenzo(c,g)(1,2)diazocine-5,6-dioxide; anticancer agents |
| 03/09/2004 | US6703380 Prevention of cancer |
| 03/09/2004 | US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity |
| 03/09/2004 | US6703050 Methods and compositions for the prevention or treatment of cancer |
| 03/09/2004 | US6703049 Angiogenesis inhibitor |
| 03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 03/09/2004 | US6702998 Methods and devices for treating lung dysfunction |
| 03/04/2004 | WO2004018000A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents |
| 03/04/2004 | WO2004017984A1 Method for cancer therapy using herbal extracts |
| 03/04/2004 | WO2004017964A1 Combination therapy for hyperproliferative diseases |
| 03/04/2004 | WO2004017937A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
| 03/04/2004 | WO2004017924A2 Methods of treating involuntary facial spasms and facial wrinkles |
| 03/04/2004 | WO2003026581A3 Pharmaceutical compositions and methods for treating cancer |
| 03/04/2004 | WO2002085459A3 Antiangiogenic combination therapy for the treatment of cancer |
| 03/04/2004 | WO2002078623A3 Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
| 03/04/2004 | US20040043971 Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| 03/04/2004 | US20040043074 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/04/2004 | US20040043048 Cosmetic containing anti-bacterial agent and process for production thereof |
| 03/04/2004 | US20040043013 Metabolic uncoupling therapy |
| 03/04/2004 | US20040042978 Mixture of stannous fluoride and zinc compound |
| 03/04/2004 | US20040040909 Dispersion of carbon particles in high pressure water; conbustion gaseous mixture of hydrogen, oxygen |
| 03/04/2004 | DE10237969A1 Forming method for high purity gold foil, involves suspending gold powder suspended above gold bullion using static electricity to be attracted and temporarily accumulated on surface of substrate |
| 03/04/2004 | CA2733212A1 Arginine silicate inositol complex and use thereof |
| 03/04/2004 | CA2496378A1 Methods of treating involuntary facial spasms and facial wrinkles |
| 03/04/2004 | CA2495962A1 Combination therapy for hyperproliferative diseases |
| 03/03/2004 | EP1393730A2 Combination chemotherapy involving topotecan and a platinum coordination compound |
| 03/03/2004 | EP1393729A2 Combination chemotherapy involving topotecan and a platinum coordination compound |
| 03/03/2004 | EP1393723A2 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 03/03/2004 | EP1392332A1 Method for the destruction of oocysts |
| 03/03/2004 | EP1392294A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/03/2004 | EP1392286A2 Antineoplastic combinations |
| 03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |
| 03/03/2004 | EP1392271A1 Swallow tablet comprising paracetamol |
| 03/03/2004 | EP1392115A1 Controlled release particles |
| 03/03/2004 | EP1125575B1 Perfusate preparation for ophthalmic operation |
| 03/03/2004 | EP0874558B8 Liquid oral compositions comprising a calcium compound and an acidulant |
| 03/03/2004 | EP0874555B1 Method and composition for reducing coffee acidity |
| 03/03/2004 | CN1479626A Compositions for preventing or ameliorating multiple risk factor syndromes |
| 03/03/2004 | CN1478536A Proprietury Chinese medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method |
| 03/03/2004 | CN1478492A Medicine for treating arthritis pain and its preparation method |
| 03/03/2004 | CN1478486A Nanometer realgar solid dispersion and its preparation method |
| 03/03/2004 | CN1140291C Stone-eliminatnig Jinyi medicine powder |
| 03/03/2004 | CN1140282C External use medicine for treating sexual disorder for male |
| 03/03/2004 | CN1140279C Medicine for treating angiocardiopathy and cerebrovascular disease |
| 03/03/2004 | CN1140275C Oral powder for treating mouth disease |
| 03/03/2004 | CN1140274C Medicine for treating osteoporosis and preparing method thereof |
| 03/03/2004 | CN1140272C Antitumor agents |
| 03/03/2004 | CN1140271C Medicine for treating vertigo |
| 03/03/2004 | CN1140270C Calcium antagonist having parathyroid hormone secretion inhibition, preparing method and use thereof |
| 03/03/2004 | CN1140264C Chewing gum containing colloidal bismuth subcitrate |
| 03/02/2004 | US6699912 Producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from aqueous solution and dissolving magma into a salting-in mixture to form semitransparent colloidal solution |
| 03/02/2004 | US6699885 Substituted benzimidazole dosage forms and methods of using same |
| 03/02/2004 | US6699510 Chlorite solution and an acid or acidulant formulation with dye to indicate where applied and rheology modifier to immobilize the composition on the teat surface and provides a barrier; mastitis treatment |
| 03/02/2004 | CA2238789C Dual component tooth whitening dentifrice |
| 03/02/2004 | CA2158137C Therapeutic compositions containing a lithium compound and silica |
| 02/26/2004 | WO2004017336A1 Process for producing ferromagnetic fine-particle exothermic element |
| 02/26/2004 | WO2004016553A2 Rare earth metal compounds, methods of making, and methods of using the same |
| 02/26/2004 | WO2004016551A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 02/26/2004 | WO2004016100A2 Nutritional supplement for adolescents |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/26/2004 | WO2003072024A3 Methods of treating vascular disease |
| 02/26/2004 | WO2003045334A3 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 02/26/2004 | WO2002098501A3 Method and apparatus for treating tumors using low strength electric fields |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | WO2002041885A3 Treatment of inflammation and associated complications using pseudohalides |
| 02/26/2004 | US20040038946 Biologically inert carrier (e.g., fullerene); a bone vector (e.g., a bisphosphonate) chemically bonded to the carrier; and a therapeutic agent chemically bonded to the carrier |